Advert - UCB – Case AUTH/3554/8/21

• Date posted
  12 December 2022
• Sanction
  Advertisement,
• Case number/s
  AUTH/3554/8/21 - Anonymous, non-contactable complainant v UCB

For promotion of Bimzelx (bimekizumab) to the public on LinkedIn, UCB was ruled in breach of the following clauses of the 2021 Code:

Clause 2 - Reducing confidence in the pharmaceutical industry

Clause 5.1 - Failing to maintain high standards

Clause 26.1 - Promoting a prescription only medicine to the public